Delineating the Epigenetic Landscape and Pro-Inflammatory Gene Expression Program Associated with RUNX1 Familial Platelet Disorder IN PARTNERSHIP WITH RUNX1 RESEARCH PROGRAM (2021-2024) Lucy Godley MD, PhD, University of Chicago Read More
CRCbioscreen Program Related Investment (2021) Gerrit Meijer, MD, PhD, the Netherlands Cancer Institute Read More
Novel EGFR Inhibitors for Non-Small Cell Lung Cancer 2022 Drug Discovery Award Michael Eck, MD, PhD, Pasi Jänne, MD, PhD, and David Scott, PhD, Dana-Farber Cancer Institute Read More
The Development of Novel Inhibitors of the Mitochondrial Protease ClpP to Treat Hematological Malignancies 2021 Drug Discovery Award Aaron Schimmer, MD, PhD, Princess Margaret Cancer Centre Read More
T-cell Reprogramming: A Strategy to Super-Charge TIL Therapy for Cancer ASPIRE Award (2021-Present) Claire Roddie, MD, PhD (Principal) and Tariq Enver, PhD, University College London (United Kingdom) Read More
The Adaptive and Innate Immune Responses to Inherited TP53 Breast Cancers in Li-Fraumeni Patients ASPIRE Award (2021-2024) Arnold Levine, PhD (Principal) Institute for Advanced Study Read More